The healthcare industry is undergoing reform and the renewable energy sector is shifting to foreign-investment-friendly auction-based strategies, while the new Civil Code and large investment projects – including healthcare digitalization and infrastructure development – are on the books in Kosovo, according to RPHS Law Partner Visar Ramaj.

Gessel has advised Genomtec on a non-brokered public offering carried out under an accelerated book-building procedure and the related private placement of the company’s newly issued shares.

Binder Groesswang has advised microbiome technology R&D company Biome Diagnostics on its investment round with Uniqa Group company SanusX. Schoenherr reportedly advised the investors.

Sobczynski and Partners has advised Tar Heel Capital on the acquisition – on behalf of its Dentity dental chain – of a 70% stake in Warsaw's Dental Medicenter. Michaliszyn Koska Saluda advised the Dental Medicenter shareholders.

Gessel has advised Wroclaw-based biopharmaceutical company Pure Biologics on receiving a PLN 12 million investment from ACRX Investments Limited.

Global law firm Baker McKenzie organized a competition and regulatory conference for pharma in Central and Eastern Europe (CEE) in Warsaw. During the conference, Baker McKenzie experts highlighted the hot topics of recent developments in EU Competition Law and Pharmaceutical Regulation that have direct effect on companies in the pharma and life sciences sector, discussing practical and pragmatic solutions with special regard to regional aspects in CEE in two round tables. The second one looked at regulatory hot topics and market access challenges in CEE and war-related changes in Ukraine.